
import styles from '../../components/cns.module.css';

<div className={styles.container}>
  <div className={styles.section}>
    <h2>Four Target Archetypes for Platform Development</h2>

    <div className={styles.archetypeCard}>
        <div className={styles.archetypeHeader}>
            <div className={styles.archetypeNumber}>1</div>
            <div className={styles.archetypeTitle}>Digital Neurodiagnostics Platform</div>
        </div>
        
        <p><strong>Strategic Rationale:</strong> AI-powered diagnostic tools with device integration, established reimbursement pathways, and strong data moat potential. Anchor acquisition candidate with clear bolt-on strategy.</p>
        
        <div className={styles.criteriaGrid}>
            <div className={styles.criteriaSection}>
                <h5>Financial Profile</h5>
                <ul className={styles.criteriaList}>
                    <li>Revenue: $40-70M (SaaS + device)</li>
                    <li>EBITDA Margin: 25-35%</li>
                    <li>Growth Rate: 20-30% CAGR</li>
                    <li>ARR Component: 60-80% of revenue</li>
                    <li>Customer LTV: 5-7 years average</li>
                    <li>Gross Margin: 70%+ software, 45%+ hardware</li>
                </ul>
            </div>
            
            <div className={styles.criteriaSection}>
                <h5>Operational Criteria</h5>
                <ul className={styles.criteriaList}>
                    <li>FDA 510(k) or De Novo clearance</li>
                    <li>Clinical validation studies published</li>
                    <li>Payer coverage decisions secured</li>
                    <li>KOL advisory network established</li>
                    <li>Direct sales force + channel partners</li>
                    <li>Data platform with AI/ML capabilities</li>
                </ul>
            </div>
        </div>

        <div className={styles.successBox}>
            <strong>Example Target Profile:</strong> EEG-based cognitive assessment platform with AI interpretation, deployed across 200+ hospitals, CPT codes established, $50M revenue, 30% EBITDA margins, management team staying post-acquisition.
        </div>

        <p><strong>Bolt-On Strategy:</strong> Adjacent diagnostic modalities (fMRI analysis, sleep studies), cognitive training software, clinical decision support tools, patient monitoring devices.</p>
        
        <div className={styles.tag}>Anchor Candidate</div>
        <div className={`${styles.tag} ${styles.low}`}>Integration Risk: Low</div>
        <div className={`${styles.tag} ${styles.low}`}>Regulatory Risk: Low</div>
        <div className={styles.tag}>Revenue Quality: High</div>
    </div>

    <div className={styles.archetypeCard}>
        <div className={styles.archetypeHeader}>
            <div className={styles.archetypeNumber}>2</div>
            <div className={styles.archetypeTitle}>Psychedelic-Derived Therapeutics</div>
        </div>
        
        <p><strong>Strategic Rationale:</strong> 505(b)(2) pathway for reformulated/derived compounds, reduced development risk, accelerated timelines, and differentiated IP position in emerging market.</p>
        
        <div className={styles.criteriaGrid}>
            <div className={styles.criteriaSection}>
                <h5>Financial Profile</h5>
                <ul className={styles.criteriaList}>
                    <li>Revenue: $10-30M (partnership/licensing)</li>
                    <li>Development Stage: Phase IIa minimum</li>
                    <li>Cash Runway: 18+ months to key milestones</li>
                    <li>Licensing Revenue: $2-5M annually</li>
                    <li>Partnership Deals: 2+ pharma collaborations</li>
                    <li>IP Portfolio: 10+ patents filed/granted</li>
                </ul>
            </div>
            
            <div className={styles.criteriaSection}>
                <h5>Operational Criteria</h5>
                <ul className={styles.criteriaList}>
                    <li>FDA IND approved for lead indication</li>
                    <li>Clinical manufacturing established</li>
                    <li>Regulatory strategy defined with FDA feedback</li>
                    <li>Key target indications: PTSD, depression, anxiety</li>
                    <li>Differentiated formulation/delivery mechanism</li>
                    <li>Academic collaborations for clinical validation</li>
                </ul>
            </div>
        </div>

        <div className={styles.highlightBox}>
            <strong>Example Target Profile:</strong> Psilocybin derivative company with novel delivery system, FDA Breakthrough Therapy designation, Phase IIa data showing efficacy in treatment-resistant depression, $15M licensing revenue from EU partner.
        </div>

        <p><strong>Integration Synergies:</strong> Cross-promotion with digital diagnostics platform, shared clinical infrastructure, combined payer discussions, accelerated patient identification and monitoring.</p>
        
        <div className={styles.tag}>Bolt-On Candidate</div>
        <div className={`${styles.tag} ${styles.medium}`}>Integration Risk: Medium</div>
        <div className={`${styles.tag} ${styles.medium}`}>Regulatory Risk: Medium</div>
        <div className={styles.tag}>Innovation Value: High</div>
    </div>

    <div className={styles.archetypeCard}>
        <div className={styles.archetypeHeader}>
            <div className={styles.archetypeNumber}>3</div>
            <div className={styles.archetypeTitle}>Mental Health Infrastructure Network</div>
        </div>
        
        <p><strong>Strategic Rationale:</strong> Hybrid clinic/virtual care platform with standardized protocols, integrated diagnostics, and value-based care contracts. Provides patient flow and data for platform companies.</p>
        
        <div className={styles.criteriaGrid}>
            <div className={styles.criteriaSection}>
                <h5>Financial Profile</h5>
                <ul className={styles.criteriaList}>
                    <li>Revenue: $25-50M (fee-for-service + VBC)</li>
                    <li>EBITDA Margin: 15-25%</li>
                    <li>Patient Volume: 10,000+ unique annually</li>
                    <li>Location Count: 15-30 sites</li>
                    <li>Payer Mix: 70%+ commercial, 20% Medicare</li>
                    <li>Utilization Rate: 80%+ capacity</li>
                </ul>
            </div>
            
            <div className={styles.criteriaSection}>
                <h5>Operational Criteria</h5>
                <ul className={styles.criteriaList}>
                    <li>Multi-state licensing and operations</li>
                    <li>EMR integration and data analytics</li>
                    <li>Quality metrics and outcomes tracking</li>
                    <li>Standardized care protocols</li>
                    <li>Provider network management</li>
                    <li>Value-based contracts with major payers</li>
                </ul>
            </div>
        </div>

        <div className={styles.highlightBox}>
            <strong>Example Target Profile:</strong> Regional mental health network with 25 locations, integrated telehealth platform, value-based contracts with 3 major payers, $35M revenue, standardized depression/anxiety treatment protocols.
        </div>

        <p><strong>Platform Integration:</strong> Captive customer base for diagnostics tools, real-world evidence generation, clinical trial site network, integrated care pathway optimization.</p>
        
        <div className={styles.tag}>Bolt-On Candidate</div>
        <div className={`${styles.tag} ${styles.high}`}>Integration Risk: High</div>
        <div className={`${styles.tag} ${styles.low}`}>Regulatory Risk: Low</div>
        <div className={styles.tag}>Synergy Potential: High</div>
    </div>

    <div className={styles.archetypeCard}>
        <div className={styles.archetypeHeader}>
            <div className={styles.archetypeNumber}>4</div>
            <div className={styles.archetypeTitle}>AI-Powered CNS Data Platform</div>
        </div>
        
        <p><strong>Strategic Rationale:</strong> Central nervous system data aggregation and analytics platform serving pharma, payers, and providers. Horizontal infrastructure play with multiple revenue streams.</p>
        
        <div className={styles.criteriaGrid}>
            <div className={styles.criteriaSection}>
                <h5>Financial Profile</h5>
                <ul className={styles.criteriaList}>
                    <li>Revenue: $15-40M (SaaS + data licensing)</li>
                    <li>EBITDA Margin: 30-45%</li>
                    <li>ARR Growth: 40%+ annually</li>
                    <li>Customer Count: 50+ enterprise clients</li>
                    <li>Data Points: 1M+ patient records</li>
                    <li>Gross Margin: 85%+ software platform</li>
                </ul>
            </div>
            
            <div className={styles.criteriaSection}>
                <h5>Operational Criteria</h5>
                <ul className={styles.criteriaList}>
                    <li>HIPAA-compliant data infrastructure</li>
                    <li>API integrations with major EMRs</li>
                    <li>Proprietary AI/ML algorithms</li>
                    <li>Real-world evidence capabilities</li>
                    <li>Multi-tenant SaaS architecture</li>
                    <li>Data partnerships with health systems</li>
                </ul>
            </div>
        </div>

        <div className={styles.successBox}>
            <strong>Example Target Profile:</strong> CNS data platform with EMR integrations at 100+ hospitals, AI models for treatment prediction, $25M ARR from pharma and payer clients, 40% EBITDA margins, growing 50% annually.
        </div>

        <p><strong>Strategic Value:</strong> Central data hub for all platform companies, cross-selling opportunities, predictive analytics for clinical development, population health insights, regulatory submission support.</p>
        
        <div className={styles.tag}>Anchor or Bolt-On</div>
        <div className={`${styles.tag} ${styles.low}`}>Integration Risk: Low</div>
        <div className={`${styles.tag} ${styles.medium}`}>Technology Risk: Medium</div>
        <div className={styles.tag}>Strategic Value: Highest</div>
    </div>
  </div>
</div>
